SCHEMBL7305720

SCHEMBL7305720

CCN(C)C(=O)NCC1(c2ccccc2)CCNCC1

nearest known ligand 0.49

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.48
LMNA P02545 4/20 0.46
SMN1; SMN2 Q16637 4/20 0.45
NPSR1 Q6W5P4 2/20 0.45
L3MBTL1 Q9Y468 2/20 0.45
OPRM1 P35372 3/20 0.44
OPRL1 P41146 1/20 0.44
TP53 P04637 2/20 0.44
GAA P10253 2/20 0.44
KCNA3 P22001 1/20 0.43
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
HSD17B10 Q99714 1/20 0.42
CNR1 P21554 1/20 0.42
POLB P06746 1/20 0.41
MAPK1 P28482 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2C19 P33261 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7305712 0.82 OPRM1 (0.53) ALDH1A1LMNASMN1; SMN2NPSR1L3MBTL1
SCHEMBL8052285 0.81 MEN1 (0.52) ALDH1A1LMNASMN1; SMN2NPSR1L3MBTL1
SCHEMBL373329 0.81 LMNA (0.52) ALDH1A1LMNASMN1; SMN2NPSR1L3MBTL1
SCHEMBL5568764 0.81 LMNA (0.55) ALDH1A1LMNASMN1; SMN2NPSR1L3MBTL1
SCHEMBL8043309 0.81 ALDH1A1 (0.55) ALDH1A1LMNASMN1; SMN2NPSR1L3MBTL1
SCHEMBL7304297 0.80 NPFFR1 (0.59) ALDH1A1LMNASMN1; SMN2L3MBTL1OPRL1
Hydrochloric Acid SCHEMBL7801197 0.80 LMNA (0.51) ALDH1A1LMNASMN1; SMN2NPSR1L3MBTL1
SCHEMBL15088436 0.77 MEN1 (0.54) ALDH1A1LMNASMN1; SMN2NPSR1L3MBTL1
SCHEMBL186987 0.75 MEN1 (0.49) ALDH1A1LMNASMN1; SMN2NPSR1L3MBTL1
SCHEMBL7305853 0.75 OPRM1 (0.45) LMNAOPRM1OPRL1KCNA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6294537-B1 NEUROKININS USED FOR TREATMENT OF DISEASES SANOFI-SYNTHELABO (FR) 2001-09-25 US disclosed
US-6124316-A ACTIVE DRUG TREATING PSYCHIATRIC DISEASES, DISEASES OF PSYCHOSOMATIC ORIGIN, OF HYPERTENSION AND, NERVOUS SYSTEM DISORDERS SANOFI (FR) 2000-09-26 US disclosed
US-5942523-A NOVEL PIPERIDINE DERIVATIVES WHOSE SPECIFIC STRUCTURE INCLUDES AT POSITION 1 AN ALKYL CHAIN HAVING A 3,4-DICHLOROPHENYL GROUP ATTACHED; HIGH SELECTIVITY TO THE NK3 RECEPTOR; UNIT DOSAGE FORM; TREATING PSYCHIATRIC DISEASES SANOFI (FR) 1999-08-24 US disclosed
US-5741910-A PIPERIDINE DERIVATIVE INTERMEDIATES SANOFI (FR) 1998-04-21 US disclosed
EP-0673928-A1 Novel N-(3,4-dichlorophenyl-propyl)-piperidine derivatives as selective human NK3-receptor antagonists SANOFI (FR) 1995-09-27 EP disclosed